Prescription medication changes following direct-to-consumer personal genomic testing: findings from the Impact of Personal Genomics (PGen) Study.

Deanna Alexis CarereTyler J VanderWeeleJason L VassyCathelijne H van der WoudenJ Scott RobertsPeter KraftRobert C Green

Published in: Genetics in medicine : official journal of the American College of Medical Genetics (2016)

Receipt of pharmacogenomic results indicating an atypical drug response is common with DTC-PGT and is associated with prescription medication changes; however, fewer than 1% of consumers report unsupervised changes at 6 months after testing.Genet Med advance online publication 22 September 2016.

Keyphrases

adverse drug
health information
healthcare
machine learning
social media
copy number
clinical decision support
genome wide